Revlimid for Myelodysplastic Syndrome
A healthcare provider may prescribe Revlimid® (lenalidomide) for the treatment of a bone marrow disease called myelodysplastic syndrome (MDS). This syndrome is a group of diseases in which the bone marrow does not make enough healthy blood cells.
People with MDS do not usually experience symptoms early in the course of the illness; however, when symptoms do occur, they are usually caused by low blood cell counts. In some people with MDS, they may have red blood cell counts that are so low they need treatment with a blood transfusion.
Revlimid is used to treat people with a certain type of MDS who require blood transfusions to treat their anemia. Although this drug is not a cure for MDS, it may reduce the need for blood transfusions.
(For more details on the benefits of using this drug for myelodysplastic syndrome, click Revlimid Uses. This article takes a look at how this drug works, whether it's safe for use in children, and possible unapproved uses.)